https://www.selleckchem.com/products/ipa-3.html
This study aimed to describe the current management practices for Kawasaki disease (KD) in Australia and New Zealand. We performed a secondary analysis on the Australian and New Zealand responses to a large international survey of clinicians' perspectives on KD diagnosis and management. There was general consensus among Australian and New Zealand clinicians regarding the indications for intravenous immunoglobulin and aspirin in the management of acute KD. There was less consensus on the dose of these agents, the definition and management
Like
Comment
Share
